| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/03/2000 | WO2000005379A1 Polynucleotide transporter protein |
| 02/03/2000 | WO2000005378A2 Streptococcus suis vaccines and diagnostic tests |
| 02/03/2000 | WO2000005377A2 Pc4 transcriptional coactivators |
| 02/03/2000 | WO2000005376A1 Pb 39, a gene dysregulated in prostate cancer, and uses thereof |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |
| 02/03/2000 | WO2000005374A2 Molecules associated with cell proliferation |
| 02/03/2000 | WO2000005373A2 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 02/03/2000 | WO2000005372A1 Human ion transport-like protein |
| 02/03/2000 | WO2000005371A1 Keratinocyte derived interferon |
| 02/03/2000 | WO2000005370A1 Orphan cytokine receptor |
| 02/03/2000 | WO2000005369A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 02/03/2000 | WO2000005368A1 Human calcium regulatory proteins |
| 02/03/2000 | WO2000005367A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 02/03/2000 | WO2000005366A2 Xiap ires and uses thereof |
| 02/03/2000 | WO2000005365A1 Human lcb kinase 1 |
| 02/03/2000 | WO2000005364A1 Protein similar to neuroendrocrine-specific protein, and encoding cdna |
| 02/03/2000 | WO2000005363A1 Method for screening of modulators of calcineurin activity |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005360A1 Sara proteins |
| 02/03/2000 | WO2000005359A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | WO2000005358A1 Methods for purifying nucleic acids |
| 02/03/2000 | WO2000005355A1 Rapid subcloning using site-specific recombination |
| 02/03/2000 | WO2000005353A2 Chorismate synthase from plants |
| 02/03/2000 | WO2000005351A2 Alkaline alpha-galactosidase |
| 02/03/2000 | WO2000005350A1 Recombinant dehydrodiconiferyl alcohol benzylic ether reductase, and methods of use |
| 02/03/2000 | WO2000005348A1 Pneumococcal nrdg protein |
| 02/03/2000 | WO2000005344A1 METHOD FOR MAINTENANCE AND PROPAGATION OF GERMLINE STEM CELLS USING MEMBERS OF THE TGF-β FAMILY OF GROWTH FACTORS |
| 02/03/2000 | WO2000005339A1 Transferring materials into cells using porous silicon |
| 02/03/2000 | WO2000005268A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | WO2000005267A1 Antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
| 02/03/2000 | WO2000005266A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | WO2000005265A2 Anti-crr2 antibodies and methods of use therefor |
| 02/03/2000 | WO2000005264A1 Novel g protein-conjugated receptor protein and dna thereof |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005253A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004770A1 Transgenic model of human oxidative stress |
| 02/03/2000 | WO2000004762A1 Regulation of circadian rhythms and flowering |
| 02/03/2000 | WO2000004761A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants |
| 02/03/2000 | WO2000004760A1 Copper transporter in ethylene signaling pathway |
| 02/03/2000 | WO1999067387A3 Novel mp-7 protein and nucleic acid molecules and uses therefor |
| 02/03/2000 | WO1999067357A3 Transformation of monocots by co-cultivating an inflorescence with agrobacterium |
| 02/03/2000 | WO1999066057A3 Inducible promoters |
| 02/03/2000 | WO1999066029A3 Gibberelin 2-oxidase |
| 02/03/2000 | WO1999064602A3 Moraxella catarrhalis polynucleotides and polypeptides |
| 02/03/2000 | WO1999064575A3 Treating cells |
| 02/03/2000 | WO1999064450A3 Cif130 inhibits cell cycle progression |
| 02/03/2000 | WO1999061628A3 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 02/03/2000 | WO1999061627A3 Mutant lactobacillus bulgaricus strains free from beta-galactoside activity |
| 02/03/2000 | WO1999061052A3 Oral immunization with papillomavirus virus-like particles |
| 02/03/2000 | WO1999061049A3 Model for infection by a pathogen using administration of nucleic acids |
| 02/03/2000 | WO1999060120A3 Soluble t cell receptor |
| 02/03/2000 | WO1999060119A3 Multivalent t cell receptor complexes |
| 02/03/2000 | WO1999060108A3 Transgenic animals produced by homologous sequence targeting |
| 02/03/2000 | WO1999060102A3 Improved in vivo production of cephalosporins |
| 02/03/2000 | WO1999059620A9 Angiostatin receptor |
| 02/03/2000 | WO1999058947A3 Modulation of molecular interaction sites on rna and other biomolecules |
| 02/03/2000 | WO1999058474A9 Generation of combinatorial libraries of compounds corresponding to virtual libraries of compounds |
| 02/03/2000 | WO1999057536A9 Cyclin activation kinase (cak) from human pathogens, and uses related thereto |
| 02/03/2000 | WO1999057277A3 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/03/2000 | WO1999054459A8 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 02/03/2000 | WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/03/2000 | WO1999052942A3 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 02/03/2000 | WO1999051773A9 Addressable protein arrays |
| 02/03/2000 | WO1999051758A8 Enzymes responsible for the metabolism of zeatin |
| 02/03/2000 | WO1999051748A3 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/03/2000 | WO1999051263A3 Methods and modified cells for the treatment of cancer |
| 02/03/2000 | WO1999050430A3 Modification of fatty acid composition in plants by expression of an aspergillus nidulans delta-9 coa desaturase |
| 02/03/2000 | WO1999046400A9 Compositions and methods for enhanced synthesis of nucleic acid molecules |
| 02/03/2000 | WO1999037783A3 Live vaccine against brucellosis |
| 02/03/2000 | WO1999037764A3 New members of the glypican gene family |
| 02/03/2000 | WO1999037143A3 Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 02/03/2000 | WO1999024589B1 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
| 02/03/2000 | DE19847779C1 Novel receptor DNA useful for identifying apoptosis-modulating substances potentially useful for cancer chemotherapy |
| 02/03/2000 | DE19836099A1 Nukleinsäuremoleküle kodierend für eine ß-Amylase, Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke Nucleic acid molecules coding for a beta-amylase, plants which synthesize a modified starch, methods for producing the plants, their use and the modified starch |
| 02/03/2000 | DE19836098A1 Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke Plants which synthesize a modified starch, methods for producing the plants, their use and the modified starch |
| 02/03/2000 | DE19836097A1 Nukleinsäuremoleküle kodierend für eine alpha-Glukosidase, Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke Nucleic acid molecules coding for an alpha-glucosidase, plants which synthesize a modified starch, methods for producing the plants, their use and the modified starch |
| 02/03/2000 | DE19834584A1 Machine purifying biological materials magnetically, employs conventional microtitration plates in conjunction with array of powerful rare earth doped permanent magnets |
| 02/03/2000 | DE19834430A1 Selbstdeletierende Vektoren für die Krebstherapie Selbstdeletierende vectors for cancer therapy |
| 02/03/2000 | DE19833738A1 Verfahren zur Isolierung von Krebszellen aus zellhaltigen Körperflüssigkeiten sowie Sets zur Durchführung dieses Verfahrens A method for isolating cancer cells from cell-containing body fluids, and kits for carrying out this method |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | DE19822108A1 Verfahren zur Detektion von Mikroorganismen in Produkten, insbesondere in Arzneimitteln und Kosmetika A method for the detection of microorganisms in products, particularly in pharmaceuticals and cosmetics |
| 02/03/2000 | CA2822466A1 Commercial production of proteases in plants |
| 02/03/2000 | CA2339045A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | CA2338561A1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | CA2338397A1 Methods for purifying nucleic acids |
| 02/03/2000 | CA2338336A1 A novel g protein-coupled receptor protein and its dna thereof |
| 02/03/2000 | CA2338312A1 A subfamily of rna helicases wich are modulators of the fidelity of translation termination and uses thereof |
| 02/03/2000 | CA2337153A1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination |
| 02/03/2000 | CA2337093A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants |
| 02/03/2000 | CA2336707A1 Xiap ires and uses thereof |
| 02/03/2000 | CA2336595A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | CA2336520A1 Rapid subcloning using site-specific recombination |
| 02/03/2000 | CA2336488A1 Recombinant dehydrodiconiferyl alcohol benzylic ether reductase, and methods of use |
| 02/03/2000 | CA2336487A1 Copper transporter in ethylene signaling pathway |
| 02/03/2000 | CA2336250A1 Anti-ccr2 antibodies and methods of use therefor |
| 02/03/2000 | CA2336225A1 Human proteins having hydrophobic domains and dnas encoding these proteins |